[go: up one dir, main page]

AU2001274966A1 - Novel long acting, reversible veterinary sedative and analgesic and method of use - Google Patents

Novel long acting, reversible veterinary sedative and analgesic and method of use

Info

Publication number
AU2001274966A1
AU2001274966A1 AU2001274966A AU7496601A AU2001274966A1 AU 2001274966 A1 AU2001274966 A1 AU 2001274966A1 AU 2001274966 A AU2001274966 A AU 2001274966A AU 7496601 A AU7496601 A AU 7496601A AU 2001274966 A1 AU2001274966 A1 AU 2001274966A1
Authority
AU
Australia
Prior art keywords
analgesic
reversible
long acting
novel long
sedative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001274966A
Inventor
Thomas Tobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of AU2001274966A1 publication Critical patent/AU2001274966A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2001274966A 2000-05-24 2001-05-24 Novel long acting, reversible veterinary sedative and analgesic and method of use Abandoned AU2001274966A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20662500P 2000-05-24 2000-05-24
US60206625 2000-05-24
PCT/US2001/016992 WO2001089508A1 (en) 2000-05-24 2001-05-24 Novel long acting, reversible veterinary sedative and analgesic and method of use

Publications (1)

Publication Number Publication Date
AU2001274966A1 true AU2001274966A1 (en) 2001-12-03

Family

ID=22767216

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001274966A Abandoned AU2001274966A1 (en) 2000-05-24 2001-05-24 Novel long acting, reversible veterinary sedative and analgesic and method of use

Country Status (3)

Country Link
US (1) US7074834B2 (en)
AU (1) AU2001274966A1 (en)
WO (1) WO2001089508A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7146335B2 (en) * 2001-03-15 2006-12-05 E*Trade Group, Inc., A Corp. Of California Online trading system having ally-initiated trading
CN102573466A (en) 2009-04-22 2012-07-11 墨卡托医疗系统公司 Use of local vascular delivery of guanethidine for the treatment of hypertension
WO2012083397A1 (en) 2010-12-22 2012-06-28 Silvestre Labs Químia E Farmaceutica Ltda. Guanabenz-containing compound for the treatment of primary cutaneous amyloidosis
CN110200963A (en) * 2011-10-19 2019-09-06 墨卡托医疗系统公司 Local modulation tissue and cell include kidney denervation to improve curative effect
US20180230105A1 (en) * 2017-01-13 2018-08-16 Regents Of The University Of Minnesota Therapeutic compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060640A (en) * 1970-04-29 1977-11-29 Shell Oil Company Therapeutic agents
US5958933A (en) 1982-11-23 1999-09-28 Naftchi; N. Eric Neurologically active compounds and compounds with multiple activities
US4742054A (en) 1982-11-23 1988-05-03 Naftchi Nosrat E Treatment of mammals suffering from damage to the central nervous system
DE3738844A1 (en) * 1987-11-16 1989-05-24 Merck Patent Gmbh ANALGESIC
US5635204A (en) * 1994-03-04 1997-06-03 Montefiore Medical Center Method for transdermal induction of anesthesia, analgesia or sedation
DE69632569T2 (en) 1995-06-09 2005-08-18 Euroceltique S.A. FORMULATIONS AND METHOD FOR EXTENDED LOCAL ANESTHESIA

Also Published As

Publication number Publication date
US7074834B2 (en) 2006-07-11
US20020091161A1 (en) 2002-07-11
WO2001089508A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001249918A1 (en) Inhibitors of inflammation and reperfusion injury and methods of use thereof
AU2001297814A1 (en) Sensing device, method of its production, and use
AU2002225356A1 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines
IL153246A0 (en) Substituted quinazoline derivatives and their use as inhibitors
MXPA03004794A (en) New mandelic acid derivatives and their use as throbin inhibitors.
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2001282267A1 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
AU2002219163A1 (en) Cryostorage method and device
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002361861A1 (en) SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
AU2001216218A1 (en) Heterocyclic analgesic compounds and method of use thereof
AU2001238690A1 (en) 3-substituted piperidines comprising urea functionality, and methods of use thereof
AU2002247208A1 (en) Selective pde3b inhibitors and use of the same in therapy
AU2001288972A1 (en) Antipsychotic sulfonamide-heterocycles, and methods of use thereof
AU2001231500A1 (en) Method and devices for preventing rock bursts, especially for use in undergroundworks
AU2001274966A1 (en) Novel long acting, reversible veterinary sedative and analgesic and method of use
AU6239501A (en) Extrusion method and extrusion device
AU2001235364A1 (en) Tetrahydronaphtalene derivatives and their use
AU2001284084A1 (en) Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof
AU1582602A (en) Drill, screw and set comprising drill and screw
AU2001247662A1 (en) Memory management apparatus and method
AU2002221222A1 (en) Novel method and use
AU2001252621A1 (en) Novel proetin and use thereof
AU2000259049A1 (en) Histidyl-proline diketopiperazine and method of use
AU2001278963A1 (en) Muo-conopeptides and their use as local anesthetics